Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04000217 · ClinicalTrials.gov registry record · NA

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

A NA study of Written Exposure Therapy and Imaginal Exposure Therapy, sponsored by Palo Alto Veterans Institute for Research.

Completed
Registry status
NA
Development phase
130
Enrollment target
1
Study location

NCT04000217: Completed NA study of Written Exposure Therapy and Imaginal Exposure Therapy, sponsored by Palo Alto Veterans Institute for Research.

NCT04000217 is a NA study of Written Exposure Therapy and Imaginal Exposure Therapy that has completed, run by Palo Alto Veterans Institute for Research. The registered enrollment target is 130 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04000217, a NA study of Written Exposure Therapy and Imaginal Exposure Therapy, has completed, sponsored by Palo Alto Veterans Institute for Research.

COMPLETED
Registry status
NA
Development phase
130 participants
Enrollment target
1
Study location

Study Summary

The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coaching from a trained peer support specialist. Treatment will be a variable length, such that 4 to 8 sessions will be delivered, depending on each participants' rate of PTSD symptom recovery.

Interventions

  • BEHAVIORAL Written Exposure Therapy
  • BEHAVIORAL Imaginal Exposure Therapy

Study Locations (1)

Illinois

  • Prevail Health Inc. - Chicago

Trial Details

FieldValue
Enrollment Target 130 participants
Start Date 2020-01-20
Est. Completion 2022-09-09
Phase NA

What the Registry Record Tells You About NCT04000217

The ClinicalTrials.gov registry entry for NCT04000217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Palo Alto Veterans Institute for Research, which has 35 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Written Exposure Therapy appearing as the primary indexed condition, and to 2 interventions - of which Written Exposure Therapy is the first listed.

NCT04000217 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04000217 about?

NCT04000217 is a clinical study titled "Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy". The purpose of the study is to compare the efficacy of two different versions of a brief online exposure therapy program for PTSD: written versus verbal trauma narrative recounting in reducing PTSD symptom severity. Both treatments will be delivered through an interactive online program with coachin...

What is the current status of trial NCT04000217?

This trial is currently completed. It is a NA study. The enrollment target is 130 participants. The study started on 2020-01-20. Estimated completion is 2022-09-09.

What conditions does trial NCT04000217 study?

This clinical trial studies the following conditions: Written Exposure Therapy, Imaginal Exposure Therapy.

What interventions are being tested in trial NCT04000217?

The interventions under investigation include: Written Exposure Therapy (BEHAVIORAL), Imaginal Exposure Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04000217?

This trial is sponsored by Palo Alto Veterans Institute for Research, which has 35 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04000217 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.